These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2099841)

  • 1. Alkylating and platinum-based agents.
    Eastman A
    Curr Opin Oncol; 1990 Dec; 2(6):1109-14. PubMed ID: 2099841
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of antitumor alkylating agents (AA).
    Teicher BA; Frei E
    Cancer Treat Res; 1991; 57():261-95. PubMed ID: 1686721
    [No Abstract]   [Full Text] [Related]  

  • 3. Alkylating agents, nitrosoureas and alkyltriazenes.
    Connors TA
    Cancer Chemother Biol Response Modif; 1987; 9():23-35. PubMed ID: 3079405
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of DNA repair in the mechanisms of cell resistance to alkylating agents and cisplatin.
    Calsou P; Salles B
    Cancer Chemother Pharmacol; 1993; 32(2):85-9. PubMed ID: 8485812
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent advances in the biochemical pharmacology of selected alkylating agents.
    Wheeler GP
    Transplant Proc; 1973 Sep; 5(3):1167-70. PubMed ID: 4738047
    [No Abstract]   [Full Text] [Related]  

  • 6. Alkylating agents, nitrosoureas and alkyltriazenes.
    Connors TA
    Cancer Chemother Biol Response Modif; 1988; 10():23-32. PubMed ID: 3079385
    [No Abstract]   [Full Text] [Related]  

  • 7. Resistance to alkylating agents and cisplatin: insights from ovarian carcinoma model systems.
    Perez RP; Hamilton TC; Ozols RF
    Pharmacol Ther; 1990; 48(1):19-27. PubMed ID: 2274575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O6-alkylguanine-DNA alkyltransferase. A target for the modulation of drug resistance.
    Gerson SL; Willson JK
    Hematol Oncol Clin North Am; 1995 Apr; 9(2):431-50. PubMed ID: 7642472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of resistance to alkylating agents.
    Colvin OM
    Cancer Treat Res; 1994; 73():249-62. PubMed ID: 7710907
    [No Abstract]   [Full Text] [Related]  

  • 10. Alkylating agents, mechanisms of resistance: a review.
    Fox BW
    Prog Clin Biol Res; 1983; 132C():247-55. PubMed ID: 6314356
    [No Abstract]   [Full Text] [Related]  

  • 11. Nucleotide excision repair: why is it not used to predict response to platinum-based chemotherapy?
    Bowden NA
    Cancer Lett; 2014 May; 346(2):163-71. PubMed ID: 24462818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anticancer chemotherapy. Prescription in the presence of renal insufficiency].
    Moulin B; Fillastre JP; Godin M; Chantrel F
    Nephrologie; 1995; 16(3):233-8. PubMed ID: 7783831
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical pharmacology of anticancer agents. (Part 1) Introduction, alkylating agents and platinum compounds].
    Fujita H
    Gan To Kagaku Ryoho; 1991 Nov; 18(14):2481-7. PubMed ID: 1952967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repair of alkylated DNA in mammalian cells.
    Roberts JJ
    Johns Hopkins Med J Suppl; 1972; (1):226-38. PubMed ID: 5066422
    [No Abstract]   [Full Text] [Related]  

  • 15. Biochemical and pharmacologic properties of nitrosoureas.
    Wang AL; Tew KD; Byrne PJ; Schein PS
    Cancer Treat Rep; 1981; 65 Suppl 3():119-24. PubMed ID: 7049367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in the frequency of N-methyl-N-nitrosourea-induced somatic mutations in Tradescantia by pretreatment with low doses of alkylating agents.
    Velemínský J; Gichner T; Satava J
    Mutat Res; 1983 Nov; 122(2):229-34. PubMed ID: 6656814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New drugs in small-cell lung cancer.
    Joss RA; Cavalli F; Goldhirsch A; Brunner KW
    Cancer Treat Rev; 1986 Sep; 13(3):157-76. PubMed ID: 3022926
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms of resistance to cisplatin and alkylating agents.
    Hamilton TC; Lai GM; Rothenberg ML; Fojo AT; Young RC; Ozols RF
    Cancer Treat Res; 1989; 48():151-69. PubMed ID: 2577136
    [No Abstract]   [Full Text] [Related]  

  • 19. [New substances in oncologic therapy].
    Cavalli F
    Schweiz Med Wochenschr; 1978 Aug; 108(32):1222-7. PubMed ID: 150028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeine potentiation of the lethal action of alkylating agents on L-cells.
    Walker IG; Reid BD
    Mutat Res; 1971 May; 12(1):101-4. PubMed ID: 5106966
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.